The REMS Companion App is an application that will allow patients, who reside within the United States, to conduct Risk Evaluation and Mitigation Strategy (REMS) patient surveys.
Keywords: REMS, Lenalidomide, Revlimid, Pomalyst, Thalomid, BMS, Bristol Myers Squibb, Celgene, Patient Survey
Keywords: REMS, Lenalidomide, Revlimid, Pomalyst, Thalomid, BMS, Bristol Myers Squibb, Celgene, Patient Survey
Show More
